Financhill
Sell
11

RCKT Quote, Financials, Valuation and Earnings

Last price:
$11.15
Seasonality move :
-13.12%
Day range:
$10.88 - $11.68
52-week range:
$10.88 - $31.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.08x
Volume:
1.8M
Avg. volume:
1.5M
1-year change:
-61.8%
Market cap:
$1B
Revenue:
--
EPS (TTM):
-$2.75

Earnings Data

Next earnings date for RCKT
Feb 26
2025
Most recent earnings per share
-$0.71
Beat by $0.04
(Nov 7/2024)
Consensus Estimate
-$0.75
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RCKT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.70 --
02/26/2025 Q4 $31.3K -- -- -$0.72 --
11/07/2024 Q3 -- -- -$0.71 -$0.75 $0.04
08/05/2024 Q2 -- -- -$0.74 -$0.72 -$0.02
05/06/2024 Q1 -- -- -$0.66 -$0.67 $0.01
02/26/2024 Q4 -- -- -$0.64 -$0.77 $0.13
11/06/2023 Q3 -- -- -$0.75 -$0.78 $0.03
08/09/2023 Q2 -- -- -$0.82 -$0.78 -$0.04
05/04/2023 Q1 -- -- -$0.73 -$0.84 $0.11
02/27/2023 Q4 -- -- -$0.89 -$0.82 -$0.07
11/03/2022 Q3 -- -- -$0.87 -$0.77 -$0.10
08/08/2022 Q2 -- -- -$0.83 -$0.68 -$0.15
05/06/2022 Q1 -- -- -$0.67 -$0.70 $0.03
02/24/2022 Q4 -- -- -$0.69 -$0.73 $0.04
11/05/2021 Q3 -- -- -$0.79 -$0.62 -$0.17
08/09/2021 Q2 -- -- -$0.55 -$0.65 $0.10
05/10/2021 Q1 -- -- -$0.65 -$0.69 $0.04
02/25/2021 Q4 -- -- -$1.09 -$0.50 -$0.59
11/04/2020 Q3 -- -- -$0.53 -$0.45 -$0.08
08/05/2020 Q2 -- -- -$0.45 -$0.50 $0.05
05/06/2020 Q1 -- -- -$0.45 -$0.45 --
03/05/2020 Q4 -- -- -$0.39 -$0.48 $0.09
11/07/2019 Q3 -- -- -$0.38 -$0.48 $0.10
08/07/2019 Q2 -- -- -$0.38 -$0.61 $0.23
05/08/2019 Q1 -- -- -$0.43 -$0.53 $0.10
03/07/2019 Q4 -- -- -$0.66 -$0.44 -$0.22
11/07/2018 Q3 -- -- -$0.40 -$0.44 $0.04
08/08/2018 Q2 -- -- -$0.40 -$0.44 $0.04
05/11/2018 Q1 -- -- -$0.28 -$0.39 $0.11
03/06/2018 Q4 -- -- -$0.18 -$0.31 $0.13

Rocket Pharmaceuticals Earnings Questions

  • How Much did Rocket Pharmaceuticals Generate in Revenue Last Quarter?

    Rocket Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Rocket Pharmaceuticals Beat Earnings Last Quarter?

    Rocket Pharmaceuticals announced earnings per share of -$0.71 which represents a beat of analyst forecast a -$0.75 per share.

  • Is Rocket Pharmaceuticals Profitable?

    Rocket Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Rocket Pharmaceuticals EPS Next Year?

    Rocket Pharmaceuticals's earnings are forecast to decrease from -$2.92 per share to -$2.81 per share next year representing a decrease of -2.47%.

  • When is Rocket Pharmaceuticals's Earnings Date?

    Rocket Pharmaceuticals's next earnings date is February 26, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock